Table 1 Baseline characteristics by treatment group
MynxGrip (n = 432) | Manual compression (n = 432) | P value | |
|---|---|---|---|
Age (years) | 66 ± 11 | 66 ± 11 | 0.99 |
Gender (male) | 285 (66%) | 285(66%) | 0.99 |
BMI (kg/m2) | 26.5 ± 4.2 | 27.1 ± 4.4 | 0.07 |
Diabetes mellitus | 67 (18%) | 80 (22%) | 0.25 |
Statin treatment | 237 (58%) | 260 (63%) | 0.15 |
Hypertension | 222 (55%) | 245 (59%) | 0.19 |
Active smoking | 82 (21%) | 96 (24%) | 0.67 |
Previous AMI | 75 (18%) | 70 (17%) | 0.64 |
Previous PCI | 92 (22%) | 95 (23%) | 0.83 |
Previous CABG | 41 (10%) | 49 (12%) | 0.55 |
Creatinine level, mmol/L | 81 [69:94] | 81 [70:95] | 0.65 |
Antithrombotic therapy | |||
Aspirin | 85 (19.7%) | 82 (19%) | 0.80 |
Clopidogrel | 22 (5.1%) | 21 (4.9%) | 0.88 |
Ticagrelor | 35 (8.1%) | 51 (11.8%) | 0.07 |
Fondaparinux | 17 (3.9%) | 20 (4.6%) | 0.61 |
Dalteparin | 10 (2.3%) | 6 (1.4%) | 0.31 |
Warfarin | 2 (0.5%) | 3 (0.7%) | 0.99 |
Heparin | 133 (30.8%) | 127 (29.4%) | 0.66 |